CID 118912975

Rezivertinib

Structural Information

Molecular Formula
C27H30N6O3
SMILES
CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=CC(=C(C=C4OC)OCCN(C)C)NC(=O)C=C
InChI
InChI=1S/C27H30N6O3/c1-6-26(34)29-22-15-21(24(35-5)16-25(22)36-14-13-32(2)3)31-27-28-12-11-20(30-27)19-17-33(4)23-10-8-7-9-18(19)23/h6-12,15-17H,1,13-14H2,2-5H3,(H,29,34)(H,28,30,31)
InChIKey
BPMZUKYFIDPLEA-UHFFFAOYSA-N
Compound name
N-[2-[2-(dimethylamino)ethoxy]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

3
References

237
Patents

486.23795 Da
Monoisotopic Mass

3.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 487.24523 220.4
[M+Na]+ 509.22717 226.7
[M-H]- 485.23067 229.3
[M+NH4]+ 504.27177 226.0
[M+K]+ 525.20111 221.4
[M+H-H2O]+ 469.23521 207.6
[M+HCOO]- 531.23615 242.6
[M+CH3COO]- 545.25180 252.1
[M+Na-2H]- 507.21262 221.6
[M]+ 486.23740 227.1
[M]- 486.23850 227.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe